logo

For the Inventor, By the Inventor

Williamsville, NY, United States of America

Terry D Connell

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: The State University of New York, The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 2005-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Terry D Connell. Retrieved from https://idiyas.com/inventor/terry-d-connell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal2 out of 2,046 
 
The State University of New York
 patents
silverMedal1 out of 641 
 
The UAB Research Foundation (The University of Alabama at Birmingham)
 patents

Years Active: 2005-2010

Loading Chart...
3 patents (USPTO):Explore Patents
1. 7776338 - Adjuvant activities of mutants of LT-IIa and LT-IIb enterotoxin lacking binding to ganglioside (2010-08-17),
2. 7455843 - Adjuvant activities of mutants of LT-IIa and LT-IIb enterotoxin lacking binding to ganglioside (2008-11-25),
3. 6846488 - Chimeric antigen-enterotoxin mucosal immunogens (2005-01-25),

Title: The Innovative Contributions of Terry D Connell

Introduction

Terry D Connell is a notable inventor based in Williamsville, NY (US). He has made significant contributions to the field of immunology through his innovative research and inventions. With a total of 3 patents, Connell's work focuses on enhancing immune responses to antigens.

Latest Patents

Connell's latest patents include groundbreaking research on the adjuvant activities of mutants of LT-IIa and LT-IIb enterotoxin lacking binding to ganglioside. The present invention describes the adjuvant activity of these mutants, specifically the LT-IIb(T13I) mutant, which demonstrates comparable adjuvant activity to the wild type LT-IIb. Additionally, the LT-IIa(T34I) mutant exhibits a late onset adjuvant activity, making these mutants valuable for enhancing immune responses.

Career Highlights

Throughout his career, Connell has worked with esteemed institutions such as the State University of New York and the UAB Research Foundation. His research has contributed to advancements in immunology and vaccine development.

Collaborations

Connell has collaborated with notable colleagues, including Michael W Russell and Hesham Nawar, who have contributed to his research endeavors.

Conclusion

Terry D Connell's innovative work in the field of immunology has led to significant advancements in enhancing immune responses. His contributions through patents and collaborations continue to impact the scientific community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…